-+ 0.00%
-+ 0.00%
-+ 0.00%

Immuneering Q4 EPS $(0.18) Beats $(0.31) Estimate

Benzinga·03/06/2026 12:48:43
Listen to the news
Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.31) by 42.31 percent. This is a 68.97 percent increase over losses of $(0.58) per share from the same period last year.